HealthMore in Health→
FDA Drug Division Leadership Faces Fresh Uncertainty as Tracy Beth Høeg Is Expected to Depart
Key Takeaways
- The head of the FDA’s drug division is expected to leave, according to a source familiar with the matter.
- The report follows the recent exit of Commissioner Marty Makary.
- The available source material does not provide a formal timeline or replacement plan.
DE
DT Editorial Team··via endpoints.news
